MDP Stock Recent News

Medexus Pharmaceuticals Inc Q3 2023 Results Conference Call February 9, 2023 8:00 AM ET Company Participants Victoria Rutherford - Investor Relations Ken d'Entremont - Chief Executive Officer Marcel Konrad - Chief Financial Officer Conference Call Participants Andre Uddin - Research Capital Rahul Sarugaser - Raymond James Prasath Pandurangan - Bloom Burton Tania Armstrong-Whitworth - Canaccord Genuity Julian Hung - Stifel Operator Greetings. Welcome to the Medexus Pharmaceuticals Third Quarter 2023 Earnings Call.

Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q2 2023 Earnings Conference Call November 9, 2022 8:00 AM ET Company Participants Victoria Rutherford - Investor Relations, Adelaide Capital Ken d'Entremont - Chief Executive Officer Marcel Konrad - Chief Financial Officer Conference Call Participants Andre Uddin - Research Capital Justin Keywood - Stifel Rahul Sarugaser - Raymond James Scott Henry - ROTH Capital Partners Prasath Pandurangan - Bloom Burton Operator Good morning, ladies and gentlemen and welcome to the Medexus Pharmaceuticals Second Quarter 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Ms.

Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q4 2022 Earnings Conference Call June 23, 2022 8:00 AM ET Company Participants Ken d'Entremont - Chief Executive Officer Marcel Konrad - Chief Financial Officer Victoria Rutherford - Investor Relations, Adelaide Capital Conference Call Participants Andre Uddin - Research Capital Scott Henry - Roth Capital Justin Keywood - Stifel Prasath Pandurangan – Bloom Burton Operator Good morning ladies and gentlemen and welcome to the Medexus Pharmaceuticals fourth quarter 2022 earnings call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation.